引用本文: | 韩宝惠, 刘思阳. ⅠB~ⅢA期非小细胞肺癌患者厄洛替尼对比安慰剂辅助治疗的疗效比较[J]. 循证医学, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008 |
Citation: | Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008 |